Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Klebsiella pneumoniae coproducing NDM-1 and OXA-232

PROVIDER: PRJNA484986 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7660990_1.fastq.gz	Fastqsanger.gz
	SRR7660990_2.fastq.gz	Fastqsanger.gz
	SRR7660991_1.fastq.gz	Fastqsanger.gz
	SRR7660991_2.fastq.gz	Fastqsanger.gz
	SRR7660992_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Klebsiella pneumoniae

Project description:OXA-232-producing Klebsiella pneumoniae

| PRJNA1001133 | ENA

Project description:OXA-232-producing Klebsiella pneumoniae

| PRJNA484098 | ENA

Clinical Evaluation of Advanced MALDI-TOF MS for Carbapenemase Subtyping in Gram-negative Isolates

Project description:The spread of carbapenemase-producing Enterobacterales (CPE) is emerging as a significant clinical concern in tertiary hospitals and in particular, long-term care facilities with deficiencies in infection control. This study aims to evaluate an advanced matrix-assisted laser desorption/ionization mass spectrometry (A-MALDI) method for the identification of carbapenemases and further discrimination of their subtypes in clinical isolates. The A-MALDI method was employed to detect CPE target proteins. Enhancements were made to improve detectability and mass accuracy through the optimization of MALDI-TOF settings and internal mass calibration. A total of 581 clinical isolates were analyzed, including 469 CPE isolates (388 KPC, 51 NDM, 40 OXA, and 2 GES) and 112 carbapenemase-negative isolates. Clinical evaluation of the A-MALDI demonstrated 100% accuracy and precision in identifying all the collected CPE isolates. Additionally, A-MALDI successfully discriminated individual carbapenemase subtypes (KPC-2 or KPC-3/4; OXA-48 or OXA-181 or OXA-232; GES-5 or GES-24) and also differentiated co-producing carbapenemase strains (KPC & NDM; KPC & OXA; KPC & GES; NDM & OXA), attributed to its high mass accuracy and simultaneous detection capability. A-MALDI is considered a valuable diagnostic tool for accurately identifying CPE and carbapenemase’s subtypes in clinical isolates. It may also aid in selecting appropriate antibiotics for each carbapenemase subtype. Ultimately, we expect that the A-MALDI method will contribute to preventing the spread of antibiotic resistance and improving human public health.

2024-11-26 | PXD058284 | Pride

Project description:OXA-232-producing Klebsiella pneumoniae genome sequencing

| PRJNA1081117 | ENA

Klebsiella pneumoniae and Echerichia coli

Project description:OXA-232 Klebsiella pneumoniae and Echerichia coli

| PRJNA801358 | ENA

Project description:OXA-232-producing multidrug resistant Klebsiella pneumoniae of sequence type 231

| PRJNA838446 | ENA

Project description:Clonal dissemination of OXA-232-producing Klebsiella pneumoniae in the environment

| PRJNA977051 | ENA

Gene expression in Klebsiella pneumoniae

Project description:Elucidating the RamA Regulon in Klebsiella pneumoniae and the transcriptome profiles of multidrug resistant Klebsiella pneumoniae

2017-12-25 | GSE24688 | GEO

Klebsiella pneumoniae

Project description:Emergence of a non-clonal OXA-232 carbapenemase-producing Klebsiella pneumoniae in France

| PRJNA832942 | ENA

Project description:Whole genome sequencing of OXA-232-producing carbapenem-resistant ST15 Klebsiella pneumoniae strains

| PRJNA975316 | ENA